Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity.
Karl Peter RheinwaltUta DrebberRobert SchierwagenSabine KleinUlf Peter NeumannTom Florian UlmerAndreas PlamperAndreas KrohSandra SchipperMargarete OdenthalFrank Erhard UschnerPhilipp LingohrJonel TrebickaMaximilian Joseph BrolPublished in: Journal of clinical medicine (2020)
Histopathological presence of NAFLD might lead to inferior postoperative weight reduction after gastric bypass surgery. The mechanisms underlying this observation should be further studied.
Keyphrases
- gastric bypass
- weight loss
- bariatric surgery
- roux en y gastric bypass
- minimally invasive
- obese patients
- coronary artery bypass
- weight gain
- surgical site infection
- glycemic control
- patients undergoing
- type diabetes
- adipose tissue
- percutaneous coronary intervention
- acute coronary syndrome
- coronary artery disease
- high fat diet induced
- solid state